U.S. Pharmaceutical Sales - Q2 2012

The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q2 2012 by Units Sold

Rank Drug Units (000)
1 (1) acetaminophen/hydrocodone
Generic
1.59% Stats
2 (1) budesonide
Generic
-28.55% Stats
3 (2) Singulair
Merck & Co., Inc.
3.72% Stats
4 (1) ProAir HFA
Teva Pharmaceuticals
-15.04% Stats
5 (1) OneTouch
-8.93% Stats
6 Nexium
AstraZeneca Pharmaceuticals, LP
-2.05% Stats
7 Cymbalta
Eli Lilly and Company
2.20% Stats
8 Lantus
Sanofi (formerly Sanofi Aventis)
-1.72% Stats
9 Advair Diskus
GlaxoSmithKline
-3.10% Stats
10 Ventolin HFA
GlaxoSmithKline
-8.57% Stats
11 (3) atorvastatin
Generic
12.83% Stats
12 (1) Crestor
AstraZeneca Pharmaceuticals, LP
2.80% Stats
13 (2) fentanyl
Generic
7.36% Stats
14 (2) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
4.82% Stats
15 (2) enoxaparin
Generic
9.75% Stats
16 (4) AndroGel
AbbVie, Inc.
-13.78% Stats
17 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
0.76% Stats
18 (7) Plavix
Bristol-Myers Squibb Company
-41.53% Stats
19 Novolog
Novo Nordisk, Inc.
0.91% Stats
20 (1) Levemir
Novo Nordisk, Inc.
3.02% Stats
21 (1) Nasonex
Merck & Co., Inc.
-2.48% Stats
22 (1) NovoLog FlexPen
Novo Nordisk, Inc.
6.67% Stats
23 (2) metoprolol
Generic
7.78% Stats
24 Abilify
Otsuka Pharmaceutical Co., Ltd
0.28% Stats
25 (3) Humalog
Eli Lilly and Company
-4.09% Stats
26 () Synthroid
Abbott Laboratories
Stats
27 (1) Januvia
Merck & Co., Inc.
3.19% Stats
28 (1) Diovan
Novartis Corporation
-3.43% Stats
29 (1) Namenda
Forest Pharmaceuticals, Inc
-2.87% Stats
30 (1) Lyrica
Pfizer Inc
-0.45% Stats
31 Zetia
Merck & Co., Inc.
-1.69% Stats
32 (4) Symbicort
AstraZeneca Pharmaceuticals, LP
3.51% Stats
33 (2) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
1.98% Stats
34 (4) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
-4.23% Stats
35 (1) Flovent HFA
GlaxoSmithKline
-6.61% Stats
36 (3) Actos
Takeda Pharmaceuticals U.S.A., Inc
-8.94% Stats
37 (22) escitalopram
Generic
123.42% Stats
38 (1) Remicade
Centocor Ortho Biotech, Inc
2.38% Stats
39 (1) Lidoderm
Endo Pharmaceuticals
1.53% Stats
40 Lovaza
GlaxoSmithKline
0.78% Stats
41 Benicar
Daiichi Sankyo
-1.76% Stats
42 (10) Lipitor
Pfizer Inc
-27.90% Stats
43 Dexilant
Takeda Pharmaceuticals U.S.A., Inc
3.06% Stats
44 (1) Restasis
Allergan, Inc
2.79% Stats
45 (2) OxyContin
0.16% Stats
46 Diovan HCT
Novartis Corporation
-3.36% Stats
47 (3) Vytorin
Merck & Co., Inc.
-8.16% Stats
48 (4) VESIcare
Astellas Pharma US
3.37% Stats
49 (4) Celebrex
Pfizer Inc
2.25% Stats
50 (1) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
-2.77% Stats
51 (3) Janumet
Merck & Co., Inc.
1.56% Stats
52 (2) Niaspan
Abbott Laboratories
-7.61% Stats
53 (3) Enbrel
Amgen Inc.
6.68% Stats
54 () Evista
Eli Lilly and Company
Stats
55 TriCor
Abbott Laboratories
-6.85% Stats
56 (2) Vyvanse
Shire US Inc
-2.78% Stats
57 Aciphex
Eisai Corporation
-3.91% Stats
58 (2) methylphenidate
Generic
-5.19% Stats
59 (2) Cialis
Eli Lilly and Company
5.61% Stats
60 (2) amphetamine/dextroamphetamine
Generic
0.61% Stats
61 (3) Epogen
Amgen Inc.
12.79% Stats
62 (4) Humira
AbbVie, Inc.
8.97% Stats
63 (2) Rituxan
Genentech, Inc (member of Roche group)
5.30% Stats
64 (1) Truvada
Gilead Sciences, Inc.
-0.52% Stats
65 (2) Rebif
5.93% Stats
66 (3) Atripla
Gilead Sciences, Inc.
-2.45% Stats
67 (3) Avastin
Genentech, Inc (member of Roche group)
3.48% Stats
68 (5) Viagra
Pfizer Inc
0.45% Stats
69 () Victoza
Novo Nordisk, Inc.
Stats
70 (1) Seroquel XR
AstraZeneca Pharmaceuticals, LP
-3.79% Stats
71 () modafinil
Generic
Stats
72 (2) Adderall XR
Shire US Inc
-10.85% Stats
73 (3) Neulasta
Amgen Inc.
1.21% Stats
74 (1) Lunesta
Sunovion Pharmaceuticals Inc.
-4.02% Stats
75 (3) Orencia
Bristol-Myers Squibb Company
5.10% Stats
76 (3) Procrit
Janssen Pharmaceuticals, Inc
7.12% Stats
77 () Mirena
Bayer Healthcare Pharmaceuticals
Stats
78 () Renvela
Genzyme Corporation
Stats
79 () Varivax
Merck & Co., Inc.
Stats
80 Aranesp
Amgen Inc.
-3.75% Stats
81 (2) Eloxatin
Sanofi (formerly Sanofi Aventis)
2.55% Stats
82 Reyataz
Bristol-Myers Squibb Company
-1.76% Stats
83 (1) Erbitux
Bristol-Myers Squibb Company
-1.50% Stats
84 (1) Isentress
Merck & Co., Inc.
4.10% Stats
85 (48) Seroquel
AstraZeneca Pharmaceuticals, LP
-85.07% Stats
86 (2) Copaxone
Teva Pharmaceuticals
6.13% Stats
87 (2) Prezista
Janssen Pharmaceuticals, Inc
5.80% Stats
88 (1) Lucentis
Genentech, Inc (member of Roche group)
-4.91% Stats
89 (1) Alimta
Eli Lilly and Company
7.47% Stats
90 (1) Neupogen
Amgen Inc.
4.12% Stats
91 (2) Prevnar 13
Wyeth
7.74% Stats
92 Herceptin
Genentech, Inc (member of Roche group)
5.16% Stats
93 (1) Velcade
Takeda Pharmaceuticals U.S.A., Inc
8.90% Stats
94 (1) Zyvox
Pfizer Inc
-2.76% Stats
95 (1) Avonex
Biogen Idec
1.54% Stats
96 (2) Gleevec
Novartis Corporation
6.33% Stats
97 () Xeloda
Roche Pharmaceuticals
Stats
98 (1) Betaseron
Bayer Healthcare Pharmaceuticals
-11.94% Stats
99 () Gilenya
Novartis Corporation
Stats
100 Incivek
Vertex Pharmaceuticals
-8.33% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web5)